Physician profile
Richard Rubin
NPI 1962478578
$41,699.30
in general payments reported to CMS, 2019-2025
49 companies · $2,485 in 2025
The $2,485 reported for 2025 was more than what 86% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $21K · 2020: $3,174 · 2021: $4,777 · 2022: $5,772 · 2023: $2,008 · 2024: $2,195 · 2025: $2,485.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,688.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,687.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $17,745.65 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $8,838.75 | 2019-2025 | Camzyos, Eliquis |
| Astrazeneca Pharmaceuticals LP | $4,252.19 | 2019-2025 | Farxiga, Brilinta |
| Amgen INC. | $1,275.74 | 2019-2025 | Repatha, Repatha |
| Abbott Laboratories | $904.57 | 2019-2025 | Thoratec Heartmate 3 Lvas Implant Kit |
| Novartis Pharmaceuticals Corporation | $772.64 | 2019-2025 | |
| Medtronic, INC. | $741.35 | 2021-2025 | Cobalt Dr Mri Surescan, Aurora Ev-Icd Mri Surescan, Corevalve Evolut R |
| Novo Nordisk INC | $614.89 | 2020-2025 | Ozempic, Wegovy, Rybelsus |
| Bayer Healthcare Pharmaceuticals INC. | $554.38 | 2021-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $535.91 | 2019-2025 | Jardiance |
| Atricure, INC. | $502.85 | 2021-2024 | |
| Merck Sharp & Dohme LLC | $484.37 | 2022-2025 | Verquvo, Capvaxive |
| Janssen Pharmaceuticals, INC | $478.27 | 2019-2024 | Xarelto |
| Sanofi-Aventis U.S. LLC | $454.61 | 2019-2024 | |
| Boston Scientific Corporation | $362.38 | 2022-2024 | Watchman |
Show all 49 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cvrx, INC. | $310.92 | 2022-2025 | Barostim Neo System |
| Edwards Lifesciences Corporation | $196.53 | 2019-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Heartflow, INC. | $177.28 | 2025 | |
| Alnylam Pharmaceuticals INC. | $169.09 | 2022-2025 | Amvuttra |
| Amarin Pharma, INC. | $161.18 | 2019-2021 | |
| Esperion Therapeutics, INC. | $157.65 | 2021-2025 | Nexletol |
| Bardy Diagnostics, INC. | $153.91 | 2019-2022 | |
| Aerin Medical INC. | $143.84 | 2025 | |
| Scpharmaceuticals INC. | $141.03 | 2023-2025 | |
| Corcept Therapeutics | $128.55 | 2024 | Korlym |
| Mentor Worldwide LLC | $120.55 | 2019 | |
| Kestra Medical Technology Services, INC. | $119.26 | 2023-2025 | Assure Wcd |
| Phathom Pharmaceuticals, INC. | $115.08 | 2024 | Voquezna |
| Actelion Pharmaceuticals US, INC. | $112.48 | 2019-2024 | Opsumit |
| Baxter Healthcare | $109.70 | 2023-2025 | Hillrom - Cardiac Ambulatory Monitor, Hillrom - Carnation Ambulatory Monitor |
| Philips North America LLC | $105.89 | 2022-2024 | (Ck4) Mcot |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $104.53 | 2023-2025 | Lifevest |
| Kiniksa Pharmaceuticals International, Plc | $80.65 | 2024 | Arcalyst |
| Regeneron Healthcare Solutions, INC. | $67.87 | 2019 | |
| Bridgebio Pharma, INC. | $66.36 | 2025 | Attruby |
| Glaxosmithkline, LLC. | $61.72 | 2025 | Shingrix |
| Chiesi USA, INC. | $58.13 | 2022-2025 | Juxtapid |
| Inspire Medical Systems, INC. | $47.07 | 2024-2025 | Inspire |
| Daiichi Sankyo INC. | $44.23 | 2020-2023 | Injectafer |
| Ge Healthcare | $33.00 | 2019-2021 | |
| Gilead Sciences, INC. | $28.17 | 2019 | |
| Arbor Pharmaceuticals, INC. | $26.84 | 2019-2021 | |
| Irhythm Technologies, INC. | $26.15 | 2024 | Zio Monitor, Zio Xt Patch |
| Vifor Pharma, INC. | $24.66 | 2020 | |
| Celgene Corporation | $24.32 | 2025 | Camzyos |
| Lilly USA, LLC | $21.34 | 2025 | Mounjaro, Zepbound |
| Azurity Pharmaceuticals, INC. | $16.65 | 2023 | Edarbi |
| Infobionic, INC | $14.41 | 2020 | |
| Medtronic Vascular, INC. | $11.71 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Rubin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.